280 related articles for article (PubMed ID: 35915501)
1. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.
George C; Echouffo-Tcheugui JB; Jaar BG; Okpechi IG; Kengne AP
BMC Med; 2022 Aug; 20(1):247. PubMed ID: 35915501
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease in low-income to middle-income countries: the case for increased screening.
George C; Mogueo A; Okpechi I; Echouffo-Tcheugui JB; Kengne AP
BMJ Glob Health; 2017; 2(2):e000256. PubMed ID: 29081996
[TBL] [Abstract][Full Text] [Related]
3. Screening for Kidney Disease in Low- and Middle-Income Countries.
Kalyesubula R; Conroy AL; Calice-Silva V; Kumar V; Onu U; Batte A; Kaze FF; Fabian J; Ulasi I
Semin Nephrol; 2022 Sep; 42(5):151315. PubMed ID: 37001337
[TBL] [Abstract][Full Text] [Related]
4. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
[TBL] [Abstract][Full Text] [Related]
6. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities.
Echouffo-Tcheugui JB; Mayige M; Ogbera AO; Sobngwi E; Kengne AP
Diabetes Res Clin Pract; 2012 Nov; 98(2):199-208. PubMed ID: 22975016
[TBL] [Abstract][Full Text] [Related]
7. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.
Tonelli M; Dickinson JA
J Am Soc Nephrol; 2020 Sep; 31(9):1931-1940. PubMed ID: 32839279
[TBL] [Abstract][Full Text] [Related]
8. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
Ke C; Liang J; Liu M; Liu S; Wang C
BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of chronic kidney disease among at-risk adults in rural Guatemala.
Nandi M; Kurschner S; Wilcox K; Flood D; Mendoza Montano C; Barnoya J; Rohloff P; Chary A
Glob Public Health; 2021 Apr; 16(4):623-638. PubMed ID: 33161879
[TBL] [Abstract][Full Text] [Related]
10. Screening and early detection of chronic kidney disease at primary healthcare.
Nagib SN; Abdelwahab S; Amin GEE; Allam MF
Clin Exp Hypertens; 2021 Jul; 43(5):416-418. PubMed ID: 33726610
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic kidney disease stages 3-5 in low- and middle-income countries in Asia: A systematic review and meta-analysis.
Suriyong P; Ruengorn C; Shayakul C; Anantachoti P; Kanjanarat P
PLoS One; 2022; 17(2):e0264393. PubMed ID: 35213610
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of diagnostic and prognostic models of chronic kidney disease in low-income and middle-income countries.
Aparcana-Granda DJ; Ascencio EJ; Carrillo Larco RM
BMJ Open; 2022 Mar; 12(3):e058921. PubMed ID: 35292503
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.
Gheewala PA; Zaidi STR; Jose MD; Bereznicki L; Peterson GM; Castelino RL
J Nephrol; 2018 Feb; 31(1):27-36. PubMed ID: 28181150
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program.
Obrador GT; Villa AR; Olvera N; Gutiérrez V; Contreras D; Reyes R
Arch Med Res; 2013 Nov; 44(8):650-4. PubMed ID: 24211753
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systematic review and meta-analysis protocol.
Zafari N; Churilov L; MacIsaac RJ; Torkamani N; Baxter H; Kiburg KV; Ekinci E
BMJ Open; 2019 Aug; 9(8):e031558. PubMed ID: 31473625
[TBL] [Abstract][Full Text] [Related]
16. Update on Existing Care Models for Chronic Kidney Disease in Low- and Middle-Income Countries: A Systematic Review.
Nkunu V; Wiebe N; Bello A; Campbell S; Tannor E; Varghese C; Stanifer J; Tonelli M
Can J Kidney Health Dis; 2022; 9():20543581221077505. PubMed ID: 35251672
[TBL] [Abstract][Full Text] [Related]
17. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
18. Benefits of screening for Chronic Kidney Disease.
Djukanović Lj
Prilozi; 2010; 31(1):249-59. PubMed ID: 20693945
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
Ene-Iordache B; Perico N; Bikbov B; Carminati S; Remuzzi A; Perna A; Islam N; Bravo RF; Aleckovic-Halilovic M; Zou H; Zhang L; Gouda Z; Tchokhonelidze I; Abraham G; Mahdavi-Mazdeh M; Gallieni M; Codreanu I; Togtokh A; Sharma SK; Koirala P; Uprety S; Ulasi I; Remuzzi G
Lancet Glob Health; 2016 May; 4(5):e307-19. PubMed ID: 27102194
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
